Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,731 | 90 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $551.09 | 13 | $0 (2023) |
| Allergan, Inc. | $466.84 | 6 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $464.94 | 11 | $0 (2024) |
| ABBVIE INC. | $317.99 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $202.00 | 3 | $0 (2024) |
| Oyster Point Pharma, Inc. | $176.66 | 9 | $0 (2024) |
| Alcon Vision LLC | $174.72 | 7 | $0 (2024) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2018) |
| Amgen Inc. | $121.84 | 1 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $108.80 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,289 | 28 | Bausch & Lomb Americas Inc. ($290.03) |
| 2023 | $450.97 | 18 | Bausch & Lomb Americas Inc. ($174.91) |
| 2022 | $349.99 | 13 | Alcon Vision LLC ($90.75) |
| 2021 | $68.19 | 4 | SUN PHARMACEUTICAL INDUSTRIES INC. ($21.95) |
| 2020 | $153.34 | 3 | Novartis Pharmaceuticals Corporation ($126.18) |
| 2019 | $81.53 | 3 | Novartis Pharmaceuticals Corporation ($56.54) |
| 2018 | $682.68 | 11 | Allergan Inc. ($209.65) |
| 2017 | $654.99 | 10 | Allergan Inc. ($240.50) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Dry eyes | ||||||
| 10/10/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Ophthalmology | ||||||
| 09/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Ophthalmology | ||||||
| 09/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: Ophthalmology | ||||||
| 08/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/31/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Dry eyes | ||||||
| 07/26/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: Ophthalmology | ||||||
| 06/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: EYE CARE | ||||||
| 06/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: Ophthalmology | ||||||
| 06/13/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/17/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $124.92 | General |
| Category: Ophthalmology | ||||||
| 04/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: EYE CARE | ||||||
| 03/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $99.80 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: EYE CARE | ||||||
| 02/27/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $132.56 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,982 | 2,701 | $349,978 | $118,508 |
| 2022 | 15 | 1,921 | 2,394 | $337,863 | $112,943 |
| 2021 | 14 | 1,993 | 2,486 | $368,986 | $128,462 |
| 2020 | 14 | 1,409 | 1,677 | $232,263 | $78,275 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 720 | 806 | $193,440 | $65,659 | 33.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 147 | 194 | $32,204 | $11,737 | 36.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 212 | 273 | $34,398 | $11,312 | 32.9% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 162 | 410 | $16,400 | $9,032 | 55.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 324 | 390 | $33,540 | $8,582 | 25.6% |
| 92134 | Imaging of retina | Office | 2023 | 162 | 166 | $14,608 | $4,320 | 29.6% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 127 | 325 | $10,205 | $3,673 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 34 | $6,936 | $2,293 | 33.1% |
| 92250 | Photography of the retina | Office | 2023 | 47 | 47 | $6,392 | $1,220 | 19.1% |
| 87809 | Detection test by immunoassay with direct visual observation for adenovirus | Office | 2023 | 12 | 21 | $840.00 | $447.79 | 53.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 35 | 35 | $1,015 | $233.24 | 23.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 674 | 749 | $179,760 | $60,779 | 33.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 242 | 286 | $36,036 | $11,210 | 31.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 112 | 143 | $23,738 | $8,836 | 37.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 324 | 362 | $31,132 | $8,066 | 25.9% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 125 | 298 | $11,920 | $6,605 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $16,902 | $6,047 | 35.8% |
| 92134 | Imaging of retina | Office | 2022 | 123 | 124 | $10,912 | $3,486 | 31.9% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2022 | 78 | 180 | $5,652 | $2,046 | 36.2% |
| 92250 | Photography of the retina | Office | 2022 | 74 | 76 | $10,336 | $1,851 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 20 | $4,080 | $1,508 | 37.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 12 | 12 | $3,468 | $1,077 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 16 | $1,328 | $654.00 | 49.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 47 | 47 | $1,363 | $324.88 | 23.8% |
| 87809 | Detection test by immunoassay with direct visual observation for adenovirus | Office | 2022 | 11 | 15 | $600.00 | $301.66 | 50.3% |
About Dr. Judith Archibold, OD
Dr. Judith Archibold, OD is a Optometrist healthcare provider based in Troy, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1871877472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judith Archibold, OD has received a total of $3,731 in payments from pharmaceutical and medical device companies, with $1,289 received in 2024. These payments were reported across 90 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,731).
As a Medicare-enrolled provider, Archibold has provided services to 7,305 Medicare beneficiaries, totaling 9,258 services with total Medicare billing of $438,188. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Troy, NY
- Active Since 10/01/2011
- Last Updated 02/11/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1871877472
Products in Payments
- XIIDRA (Drug) $333.42
- MIEBO (Drug) $301.76
- LUMIGAN (Drug) $260.09
- RESTASIS (Drug) $248.28
- OZURDEX (Drug) $240.03
- Izervay (Drug) $202.00
- TYRVAYA (Drug) $176.66
- CEREZYME (Drug) $125.00
- TEPEZZA (Biological) $121.84
- IC-8 Apthera IOL (Device) $116.71
- SIMBRINZA (Biological) $109.69
- Syfovre (Drug) $108.80
- Prokera (Device) $103.38
- OMIDRIA (Drug) $100.43
- ACTHAR (Biological) $99.80
- Rhopressa (Drug) $97.88
- ILEVRO (Drug) $96.27
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $88.00
- Vabysmo (Drug) $77.94
- EYLEA (Biological) $69.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Troy
Dr. Erika Poikey, Od, OD
Optometrist — Payments: $5,599
Erik Ebbing, Od, OD
Optometrist — Payments: $4,963
Dr. Thomas Unger, O.d, O.D
Optometrist — Payments: $3,423
Dr. Jennifer Hoying, O.d, O.D
Optometrist — Payments: $3,123
Melissa Schultz, O.d, O.D
Optometrist — Payments: $3,091
Lina Halwaji, O.d, O.D
Optometrist — Payments: $2,985